GMAB
Genmab A/S
$35.96
Earnings Summary
Revenue | $5451Mn |
Net Profits | $3378Mn |
Net Profit Margins | 61.97% |
Highlights
Genmab A/S’s revenue jumped 604.34% since last year same period to $5451Mn in the Q2 2020. On a quarterly growth basis, Genmab A/S has generated 511.1% jump in its revenue since last 3-months.
Genmab A/S’s net profit jumped 3879.5% since last year same period to $3378Mn in the Q2 2020. On a quarterly growth basis, Genmab A/S has generated 1155.76% jump in its net profits since last 3-months.
Genmab A/S’s net profit margin jumped 465% since last year same period to 61.97% in the Q2 2020. On a quarterly growth basis, Genmab A/S has generated 105.49% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Genmab A/S post its latest quarter earnings
EPS Estimate Current Quarter | 0.13 |
EPS Estimate Current Year | 0.13 |
Highlights
Genmab A/S’s earning per share (EPS) estimates for the current quarter stand at 0.13 - a -64.13% fall from last quarter’s estimates.
Genmab A/S’s earning per share (EPS) estimates for the current year stand at 0.13.
Key Ratios
Key ratios of the Genmab A/S post its Q1 2023 earnings
Earning Per Share (EPS) | 0 |
Highlights
Genmab A/S’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2023. This indicates that the Genmab A/S has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2019-06-30 | 0.27 | 0.2 | -25.93% |
2019-12-31 | 3.43 | 3.41 | -0.58% |
2019-09-30 | 0.36 | 1.23 | 241.67% |
Company Information
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund.
Organisation | Genmab A/S |
Headquarters | Kalvebod Brygge 43, Copenhagen, Denmark, 1560 |
Employees | 1660 |
Industry | Health Technology |
CEO | Jan van de Winkel |
Discover More Earning Stocks in Health Technology Sector
Trading and brokerage services provided by
Banking and Remittance services provided by
Technology services provided by : Finzoomers Services Private Limited
Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*